Carlyle Acquires Knack RCM and EqualizeRCM

Hindustan Times reports that global investment firm Carlyle (NASDAQ: CG) has acquired a majority stake in Knack RCM and EqualizeRCM to create an AI-native, global multi-specialty RCM platform. The article states equity for the deal will come from funds affiliated with Carlyle Asia Partners VI (CAP VI) and Carlyle Asia Partners Growth II (CAPG II), and that the terms of the transaction were not disclosed. Hindustan Times reports that founders Rajiv Sharma (Knack) and Nagi Rao (Equalize) will remain invested through a reinvestment of a portion of their proceeds.

Per Hindustan Times, Knack brings scaled delivery across the U.S., India, and the Philippines anchored by an orchestration platform called Workmate. The report describes EqualizeRCM as contributing U.S. and India delivery scale plus a proprietary payer-enrollment platform and AI-driven tools such as Bill Smart for denial prediction and avoidance. The article states Equalize's platform is built on large language models and agentic AI and cites commercial traction including displacement of established vendor contracts at leading DME manufacturers.

Industry-pattern observations: health-care RCM vendors increasingly adopt LLM-based components and agentic workflows for tasks like claims triage, denial prediction, and payer communications. For practitioners, productionizing such systems commonly raises integration, data governance, privacy, and auditability requirements, particularly where PHI and regulatory compliance are involved. Observers also note that replacing incumbent RCM vendors tends to require domain-specific rule systems plus training data tied to payer behaviors.

Editorial analysis: private-equity-led consolidation in health-tech often accelerates standardization and investment in automation. For ML engineers and product leaders, this transaction signals continued capital flow into applied AI for operational healthcare functions rather than frontier-model research. The commercial emphasis on denial prediction and orchestration highlights demand for models that combine structured claim logic with unstructured-text understanding.

• •Whether the combined platform publishes technical case studies or benchmarks for denial-prediction accuracy and throughput.
• •How the platform handles PHI governance, model explainability, and payer-specific drift.
• •Customer retention and vendor-displacement evidence in DME, anesthesia, and rural-hospital segments.